BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant

Better adjuvants are needed for vaccines against seasonal influenza. TLR7 agonists are potent activators of innate immune responses and thereby may be promising adjuvants. Among the imidazoquinoline compounds, 1-benzyl-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine (BBIQ) was reported to be a highly acti...

Full description

Saved in:
Bibliographic Details
Published in:Hum Vaccin Immunother
Main Authors: Kaushik, Deepender, Dhingra, Simran, Patil, Madhuri T., Piplani, Sakshi, Khanna, Varun, Honda-Okubo, Yoshikazu, Li, Lei, Fung, Johnson, Sakala, Isaac G., Salunke, Deepak B., Petrovsky, Nikolai
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482670/
https://ncbi.nlm.nih.gov/pubmed/32298200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1710409
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items